This study evaluated demographic profile, lifestyle, comorbidities, and clinical classification of patients with HCC and their association with VEGF-A polymorphisms, a key angiogenic factor in the development of HCC [12]. This evidence concerns the gene VEGFA and hepatocellular carcinoma.